User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 4 results.
    • Speech
    Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
    Raghav, Kanwal Pratap Singh Yoshino, Takayuki Guimbaud, Rosine Chau, Ian Van den Eynde, Marc[UCL] Maurel, Joan Tie, Jeanne Kim, Tae Won Yeh, Kun-Huei Barrios, Daniel Kobayashi, Kojiro Bako, Emarjola Aregay, Mehreteab Meinhardt, Gerold Siena, Salvatore (2021) 2021 ASCO Annual Meeting I —
    • Speech
    Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
    Van Cutsem, Eric Peeters, Marc[UCL] Siena, Salvatore Humblet, Yves[UCL] Hendlisz, Alain Neyns, Bart Canon, Jean-Luc Van Laethem, Jean-Luc Maurel, Joan Richardson, Gary Wolf, Michael Amado, Rafael G. (2007) The 31st European Society of Medical Oncology Congress — Istanbul(Turkey)
    • Speech
    Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial
    Siena, Salvatore Humblet, Yves[UCL] Van Cutsem, Eric Peeters, Marc Hendlisz, Alain Neyns, Bart Canon, Jean-Luc Van Laethem, Jean-Luc Maurel, Joan Richardson, Gary (2006) 30th Congress of the European-Society-for-Medical-Oncology — Istanbul (Turkey)
    • Speech
    Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
    Raghav, Kanwal Pratap Singh Yoshino, Takayuki Guimbaud, Rosine Chau, Ian Van den Eynde, Marc[UCL] Maurel, Joan Tie, Jeanne Kim, Tae Won Yeh, Kun-Huei Barrios, Daniel Kobayashi, Kojiro Bako, Emarjola Aregay, Mehreteab Meinhardt, Gerold Siena, Salvatore (2022) 2022 ASCO Gastrointestinal Cancers Symposium —